These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34086676)

  • 21. 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005.
    Barrett AD; Monath TP; Barban V; Niedrig M; Teuwen DE
    Vaccine; 2007 Apr; 25(15):2758-65. PubMed ID: 17368349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eliminating yellow fever epidemics in Africa: Vaccine demand forecast and impact modelling.
    Jean K; Hamlet A; Benzler J; Cibrelus L; Gaythorpe KAM; Sall A; Ferguson NM; Garske T
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008304. PubMed ID: 32379756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yellow fever in a Brazilian family returning from vacation in an endemic area: relevant clinical features and epidemiological issues.
    Chaves TS; Vasconcelos MJ; Filho NO; Alves JR
    J Travel Med; 2009; 16(6):433-5. PubMed ID: 19930387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seasonal and inter-annual drivers of yellow fever transmission in South America.
    Hamlet A; Gaythorpe KAM; Garske T; Ferguson NM
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008974. PubMed ID: 33428623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importation of yellow fever into China: assessing travel patterns.
    Wilder-Smith A; Leong WY
    J Travel Med; 2017 Jul; 24(4):. PubMed ID: 28426111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of yellow fever in Africa.
    Mutebi JP; Barrett AD
    Microbes Infect; 2002 Nov; 4(14):1459-68. PubMed ID: 12475636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat.
    Waggoner JJ; Rojas A; Pinsky BA
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30021822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk assessment of yellow fever urbanization in Rio de Janeiro, Brazil.
    Codeço CT; Luz PM; Struchiner CJ
    Trans R Soc Trop Med Hyg; 2004 Dec; 98(12):702-10. PubMed ID: 15485700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease.
    Silva NIO; Sacchetto L; de Rezende IM; Trindade GS; LaBeaud AD; de Thoisy B; Drumond BP
    Virol J; 2020 Jan; 17(1):9. PubMed ID: 31973727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Yellow Fever].
    Vasconcelos PF
    Rev Soc Bras Med Trop; 2003; 36(2):275-93. PubMed ID: 12806465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow fever: the recurring plague.
    Tomori O
    Crit Rev Clin Lab Sci; 2004; 41(4):391-427. PubMed ID: 15487593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yellow fever surveillance and outbreak response: revision of case definitions, October 2010.
    Wkly Epidemiol Rec; 2010 Nov; 85(47):465-72. PubMed ID: 21090394
    [No Abstract]   [Full Text] [Related]  

  • 34. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination.
    Vázquez S; Valdés O; Pupo M; Delgado I; Alvarez M; Pelegrino JL; Guzmán MG
    J Virol Methods; 2003 Jun; 110(2):179-84. PubMed ID: 12798246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of IgM capture ELISA with a commercial rapid immunochromatographic card test & IgM microwell ELISA for the detection of antibodies to dengue viruses.
    Sathish N; Manayani DJ; Shankar V; Abraham M; Nithyanandam G; Sridharan G
    Indian J Med Res; 2002 Feb; 115():31-6. PubMed ID: 12138661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of yellow fever virus in selected health facilities in Western Kenya from 2010 to 2012.
    Kwallah Ao; Inoue S; Thairu-Muigai AW; Kuttoh N; Morita K; Mwau M
    Jpn J Infect Dis; 2015; 68(3):230-4. PubMed ID: 25672346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of Yellow fever virus outside the Amazon Basin, causing epidemics in Southeast Brazil, from 2016 to 2018.
    Rezende IM; Sacchetto L; Munhoz de Mello É; Alves PA; Iani FCM; Adelino TÉR; Duarte MM; Cury ALF; Bernardes AFL; Santos TA; Pereira LS; Dutra MRT; Ramalho DB; de Thoisy B; Kroon EG; Trindade GS; Drumond BP
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006538. PubMed ID: 29864115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yellow fever in Africa and South America, 2007.
    Wkly Epidemiol Rec; 2009 Mar; 84(13):97-104. PubMed ID: 19326583
    [No Abstract]   [Full Text] [Related]  

  • 39. Yellow fever: a disease that has yet to be conquered.
    Barrett AD; Higgs S
    Annu Rev Entomol; 2007; 52():209-29. PubMed ID: 16913829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.
    Gibney KB; Edupuganti S; Panella AJ; Kosoy OI; Delorey MJ; Lanciotti RS; Mulligan MJ; Fischer M; Staples JE
    Am J Trop Med Hyg; 2012 Dec; 87(6):1112-5. PubMed ID: 23109371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.